Clinical importance of tolerance to vancomycin in Streptococcus pneumoniae

2007, Number 79

Rev Enfer Infec Pediatr 2007; 20.21 (79)

Cardoso HG, Velázquez GN

Language: Spanish
References: 7
Page: 51-53
PDF size: 67.33 Kb.

Text Extraction

No abstract

REFERENCES

Liu HH, Tomasz A. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis 1985;152:365-72.
Mitchell L, Tuomanen E. Vancomycin-tolerant Streptococcus pneumoniae and its clinical significance. Pediatr Infect Dis J. 2001;20: 531-3.
Robertson GT, Zhao J, Desai BV, Coleman WH, Nicas TI, et al. Vancomycin tolerance induced by erythromycin but not by loss of vncRS, vex3, or pep27 function in Streptococcus pneumoniae. J Bacteriol 2002; 184: 6987-7000.
Henriques Normark B, Novak R, Ortqvist A, Kallenius G, Tuomanen E, Normark S. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis 2001;15:552-8.
Goessens WH.Basic mechanisms of bacterial tolerance of antimicrobial agents. Eur J Clin Microbiol Infect Dis 1993;12 Suppl 1:S9-12.
Charpentier E, Tuomanen E. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect 2000;2:1855-64.
Rodriguez CA, Atkinson R, Bitar W, Whitney CG, Edwards KM, et al. Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact. J Infect Dis 2004;190:1481-7.